关注
Joseph G. Ibrahim
Joseph G. Ibrahim
在 bios.unc.edu 的电子邮件经过验证 - 首页
标题
引用次数
年份
Bayesian joint modeling of multivariate longitudinal and survival outcomes using Gaussian copulas
S Cho, MA Psioda, JG Ibrahim
Biostatistics, kxae009, 2024
2024
Prior Effective Sample Size When Borrowing on the Treatment Effect Scale
H Zhang, KM Anderson, Z Zimmer, G Golm, A Sapre, JG Ibrahim
arXiv preprint arXiv:2404.13366, 2024
2024
Bayesian design of clinical trials using the scale transformed power prior
X Chen, B Nifong, EM Alt, MA Psioda, JG Ibrahim
Journal of Biopharmaceutical Statistics, 1-20, 2024
2024
BayesPPDSurv: An R Package for Bayesian Sample Size Determination Using the Power and Normalized Power Prior for Time-To-Event Data
Y Shen, MA Psioda, JG Ibrahim
arXiv preprint arXiv:2404.05118, 2024
2024
Exploring the Connection Between the Normalized Power Prior and Bayesian Hierarchical Models
Y Shen, MA Psioda, LM Carvalho, JG Ibrahim
arXiv preprint arXiv:2404.02453, 2024
12024
Efficient computation of high-dimensional penalized generalized linear mixed models by latent factor modeling of the random effects
HM Heiling, NU Rashid, Q Li, XL Peng, JJ Yeh, JG Ibrahim
Biometrics 80 (1), ujae016, 2024
12024
Safety signal detection with control of latent factors
X Tan, W Wang, D Zeng, GF Liu, G Diao, N Jafari, EM Alt, JG Ibrahim
Statistics in Medicine, 2024
2024
Canopy2: tumor phylogeny inference by bulk DNA and single-cell RNA sequencing
AMK Weideman, R Wang, JG Ibrahim, Y Jiang
bioRxiv, 2024.03. 18.585595, 2024
2024
Deeply Learned Generalized Linear Models with Missing Data
DK Lim, NU Rashid, JB Oliva, JG Ibrahim
Journal of Computational and Graphical Statistics, 1-13, 2023
2023
Discussion of “Optimal test procedures for multiple hypotheses controlling the familywise expected loss” by Willi Maurer, Frank Bretz, and Xiaolei Xun
LM LaVange, EM Alt, JG Ibrahim
Biometrics 79 (4), 2802-2805, 2023
12023
Bayesian design of multi‐regional clinical trials with time‐to‐event endpoints
NW Bean, JG Ibrahim, MA Psioda
Biometrics 79 (4), 3586-3598, 2023
22023
Bayesian design of clinical trials using joint models for recurrent and terminating events
J Xu, MA Psioda, JG Ibrahim
Biostatistics 24 (4), 866-884, 2023
2023
Supporting Information for Deeply-Learned Generalized Linear Models with Missing Data
DK Lim, NU Rashid, JB Oliva, JG Ibrahim
2023
Bayesian joint models for multi-regional clinical trials
NW Bean, JG Ibrahim, MA Psioda
Biostatistics, kxad023, 2023
2023
Bayesian bi-level variable selection for genome-wide survival study
E Lee, JG Ibrahim, H Zhu, Alzheimer’s Disease Neuroimaging Initiative
Genomics & Informatics 21 (3), 2023
2023
Estimating cell type composition using isoform expression one gene at a time
HM Heiling, DR Wilson, NU Rashid, W Sun, JG Ibrahim
Biometrics 79 (2), 854-865, 2023
12023
Bayesian generalized linear low rank regression models for the detection of vaccine‐adverse event associations
P Hauser, X Tan, F Chen, JG Ibrahim
Statistics in Medicine 42 (12), 2009-2026, 2023
2023
A Bayesian approach to study design and analysis with type I error rate control for response variables of mixed types
EM Alt, MA Psioda, JG Ibrahim
Statistics in Medicine 42 (11), 1722-1740, 2023
12023
glmmpen: High dimensional penalized generalized linear mixed models
HM Heiling, NU Rashid, Q Li, JG Ibrahim
arXiv preprint arXiv:2305.08204, 2023
22023
New C‐indices for assessing importance of longitudinal biomarkers in fitting competing risks survival data in the presence of partially masked causes
MT Sheikh, MH Chen, JA Gelfond, W Sun, JG Ibrahim
Statistics in Medicine 42 (9), 1308-1322, 2023
12023
系统目前无法执行此操作,请稍后再试。
文章 1–20